Ladenburg Thalmann Financial Services’s BeOne Medicines Ltd ONC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
$57K Sell
345
-107
-24% -$17.8K ﹤0.01% 3443
2019
Q3
$55K Buy
452
+9
+2% +$1.2K ﹤0.01% 3382
2019
Q2
$55K Buy
443
+88
+25% +$11.2K ﹤0.01% 3395
2019
Q1
$47K Buy
355
+191
+116% +$25.8K ﹤0.01% 3448
2018
Q4
$23K Sell
164
-5
-3% -$663 ﹤0.01% 3793
2018
Q3
$29K Buy
+169
New +$28.4K ﹤0.01% 3675

Other funds holding ONC

Ladenburg Thalmann Financial Services's ONC Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services reduced its BeOne Medicines Ltd (ONC) stake by 24% in Q4 2019, selling an estimated $17.8K and leaving 345 shares worth $57K. The position accounts for ﹤0.01% of the portfolio, ranked #3443.

Ladenburg Thalmann Financial Services first reported a position in ONC in Q3 2018 and has held it in 6 quarters since. 221 funds tracked by Wall St. Rank hold ONC as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 345 shares of BeOne Medicines Ltd worth $57K as of Q4 2019.
  • Ladenburg Thalmann Financial Services sold 107 BeOne Medicines Ltd shares in Q4 2019, an estimated $17.8K.
  • BeOne Medicines Ltd made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #3443 holding.
  • Ladenburg Thalmann Financial Services first reported a position in BeOne Medicines Ltd in Q3 2018 and has held it in 6 quarters since.
  • 221 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.